MSV
BSX icon

MN Services Vermogensbeheer’s Boston Scientific BSX Stock Holding History

MN Services Vermogensbeheer’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5M Sell
433,013
-135,500
-24% -$7.36M 0.14% 151
2026
Q1 		$35.7M Sell
568,513
-4,400
-0.8% -$352K 0.24% 91
2025
Q4 		$54.6M Buy
572,913
+10,113
+2% +$991K 0.34% 64
2025
Q3 		$54.9M Buy
562,800
+9,800
+2% +$1.01M 0.36% 62
2025
Q2 		$59.4M Buy
553,000
+12,700
+2% +$1.29M 0.41% 47
2025
Q1 		$54.5M Sell
540,300
-38,400
-7% -$3.87M 0.42% 48
2024
Q4 		$51.7M Buy
578,700
+10,200
+2% +$898K 0.35% 57
2024
Q3 		$47.6M Sell
568,500
-10,600
-2% -$836K 0.33% 60
2024
Q2 		$44.6M Sell
579,100
-13,200
-2% -$966K 0.32% 65
2024
Q1 		$40.6M Sell
592,300
-90,200
-13% -$5.8M 0.29% 76
2023
Q4 		$39.5M Sell
682,500
-21,500
-3% -$1.15M 0.36% 75
2023
Q3 		$37.2M Buy
704,000
+13,400
+2% +$703K 0.36% 74
2023
Q2 		$37.4M Buy
+690,600
New +$36.1M 0.35% 73
2019
Q3 		– Sell
-237,911
Closed -$10.2M – 385
2019
Q2 		$10.2M Hold
237,911
– – 0.12% 184
2019
Q1 		$9.13M Buy
237,911
+3,300
+1% +$126K 0.11% 205
2018
Q4 		$7.25M Buy
234,611
+13,200
+6% +$479K 0.11% 196
2018
Q3 		$8.52M Buy
221,411
+5,400
+2% +$189K 0.2% 111
2018
Q2 		$7.06M Hold
216,011
– – 0.18% 129
2018
Q1 		$5.9M Buy
216,011
+3,000
+1% +$81.5K 0.15% 155
2017
Q4 		$4.4M Sell
213,011
-12,800
-6% -$353K 0.14% 174
2017
Q3 		$6.59M Buy
225,811
+2,000
+0.9% +$55.2K 0.17% 136
2017
Q2 		$6.2M Buy
223,811
+187,496
+516% +$4.98M 0.17% 136
2017
Q1 		$844K Buy
36,315
+1,535
+4% +$37.3K 0.16% 137
2016
Q4 		$713K Hold
34,780
– – 0.15% 160
2016
Q3 		$828K Buy
34,780
+717
+2% +$17.1K 0.17% 139
2016
Q2 		$717K Buy
34,063
+446
+1% +$9.65K 0.17% 139
2016
Q1 		$555K Buy
+33,617
New +$591K 0.13% 181

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MN Services Vermogensbeheer's BSX Position: Q2 2026 in Review

MN Services Vermogensbeheer reduced its Boston Scientific (BSX) stake by 24% in Q2 2026, selling an estimated $7.36M and leaving 433,013 shares worth $18.5M. The position accounts for 0.14% of the portfolio, ranked #151.

MN Services Vermogensbeheer first reported a position in BSX in Q1 2016 and has held it in 27 quarters since. The position peaked at $59.4M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • MN Services Vermogensbeheer held 433,013 shares of Boston Scientific worth $18.5M as of Q2 2026.
  • MN Services Vermogensbeheer sold 135,500 Boston Scientific shares in Q2 2026, an estimated $7.36M.
  • Boston Scientific made up 0.14% of MN Services Vermogensbeheer's portfolio in Q2 2026, its #151 holding.
  • MN Services Vermogensbeheer first reported a position in Boston Scientific in Q1 2016 and has held it in 27 quarters since.
  • MN Services Vermogensbeheer's Boston Scientific position peaked at $59.4M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.